Search Results 1111-1120 of 16328 for Chronic Lymphocytic Leukemia
The primary purpose for this study is to assess if any relationship exists between participation in the Fibromyalgia and Chronic Fatigue Clinic (FCFC) class ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Large B-cell lymphoma with IRF4 rearrangement. Primary cutaneous DLBCL, leg type. EBV positive DLBCL, NOS. DLBCL associated with chronic inflammation.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Kidneys filter wastes and excess fluids from the blood, which are then excreted in the urine. Treatment for chronic kidney disease focuses on slowing the ...
Neurostimulation System when used to treat acute cluster attacks in chronic cluster headache patients. Participation eligibility. Participant eligibility ...
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). Print details. Share; Facebook ...
... leukemia who are undergoing chemotherapy. Caspofungin acetate or fluconazole may help prevent fungal infections caused by chemotherapy. It is not yet known ...
Diagnosis Arm A: CLL (including SLL), DLBCL, or ... CLL with a ... Documented current central nervous system involvement by leukemia or lymphoma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.